Skip to main content

Chlorthalidone News

FDA Approves HemiClor (chlorthalidone) for the Treatment of Hypertension

West Conshohocken, PA—April 16, 2025—PRM Pharma, LLC today announced the U.S. Food and Drug Administration (FDA) approval of HemiClor (12.5 mg chlorthalidone) tablets for the treatment of hyp...

FDA Approves Edarbyclor (azilsartan medoxomil and chlorthalidone) for the Treatment of Hypertension

DEERFIELD, Ill. and OSAKA, Japan, Dec. 20, 2011 /PRNewswire/ – Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., announced...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Edema, High Blood Pressure, Hypertension

Chlorthalidone patient information at Drugs.com